Literature DB >> 3994902

Protein binding of theophylline.

D C Buss, P Ebden, S Baker, P A Routledge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3994902      PMCID： PMC1463821          DOI： 10.1111/j.1365-2125.1985.tb02684.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Binding of theophylline and its metabolites to human plasma proteins.

Authors:  U Gundert-Remy; R Hildebrandt
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

2.  Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.

Authors:  C Knott; M Bateman; F Reynolds
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

3.  Factors influencing theophylline serum protein binding.

Authors:  L M Shaw; L Fields; R Mayock
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875

4.  Lipid-protein interactions: NMR study of melittin and its binding to lysophosphatidylcholine.

Authors:  J de Bony; J Dufourcq; B Clin
Journal:  Biochim Biophys Acta       Date:  1979-04-19

5.  Determinants of the plasma protein binding of theophylline in health.

Authors:  D Buss; D Leopold; A P Smith; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

6.  Free and total plasma theophylline concentrations in chronic airflow obstruction.

Authors:  P Ebden; D Leopold; A P Smith; D Buss; P A Routledge
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

7.  Dose-dependency of theophylline clearance and protein binding.

Authors:  J A Fleetham; C E Bird; K Nakatsu; R D Wigle; P W Munt
Journal:  Thorax       Date:  1981-05       Impact factor: 9.139
  7 in total
  4 in total

Review 1.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

2.  Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.

Authors:  J Blanchard; S Harvey; W J Morgan
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

Review 3.  Pharmacokinetic optimisation of asthma treatment.

Authors:  A M Taburet; B Schmit
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

4.  A "Single-Use" Ceramic-Based Electrochemical Sensor Chip Using Molecularly Imprinted Carbon Paste Electrode.

Authors:  Aaryashree No Family Name; Yuuto Takeda; Momoe Kanai; Akihiko Hatano; Yasuo Yoshimi; Masahito Kida
Journal:  Sensors (Basel)       Date:  2020-10-16       Impact factor: 3.576
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.